Not sure that is accurate given this was a key part of discussions leading into CR with instos (including underwritters), AGM (Beverley) and Simon running series with HNW shareholders.
Unless Beverley is a world class poker player, China seems to suggest they're holding a good deck hand. Noting (with no intended stereotyping) the Chinese themselves are not averse to such games.
Beverley's update has confirmed (1) the protracted stepped process (2) BP can't wrap their business models around our repurpose exclusive Bene proposition. Mid Pharma however have greater flexibility
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-226
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $71.79M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 20.5¢ | $16.32K | 77.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 89251 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 52634 | 5 |
View Market Depth
| Last trade - 10.38am 11/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |